---
title: "GH.US (GH.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GH.US/news.md"
symbol: "GH.US"
name: "GH.US"
parent: "https://longbridge.com/en/quote/GH.US.md"
datetime: "2026-05-19T18:44:47.726Z"
locales:
  - [en](https://longbridge.com/en/quote/GH.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GH.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GH.US/news.md)
---

# GH.US (GH.US) — Related News

### [Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GH Stock News](https://longbridge.com/en/news/286818381.md)
*2026-05-18T12:51:00.000Z*
> Guardant Health, Inc. announced the approval of restricted stock units (RSUs) for 267 new non-executive employees, total

### [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
*2026-05-18T03:55:26.000Z*
> Manulife Singapore will launch the Shield™ multi-cancer detection test in May 2026 through its partnership with Guardant

### [World Investment Advisors Purchases New Position in Guardant Health, Inc. $GH](https://longbridge.com/en/news/286670715.md)
*2026-05-17T11:09:15.000Z*
> World Investment Advisors acquired a new stake in Guardant Health, Inc. (NASDAQ:GH) by purchasing 16,290 shares valued a

### [Guardant Health (GH) Gets a Buy from Wells Fargo](https://longbridge.com/en/news/286044830.md)
*2026-05-12T06:17:30.000Z*
> Wells Fargo analyst Brandon Couillard has maintained a Buy rating on Guardant Health (GH) with a price target of $125.00

### [BTIG Reaffirms Their Buy Rating on Guardant Health (GH)](https://longbridge.com/en/news/285844932.md)
*2026-05-10T13:43:15.000Z*
> BTIG analyst Mark Massaro has reaffirmed a Buy rating on Guardant Health (GH) with a price target of $145.00, while the 

### [Guardant Health (GH) Earnings Spotlight Revenue Growth Versus Persistent Losses Challenges Premium Valuation Narratives](https://longbridge.com/en/news/285808535.md)
*2026-05-09T10:21:35.000Z*
> Guardant Health (GH) reported FY 2025 Q4 revenue of $281.3 million, with a basic EPS loss of $1.00 and a net income loss

### [JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) Stock](https://longbridge.com/en/news/285763102.md)
*2026-05-08T18:35:19.000Z*
> JPMorgan Chase & Co. has raised its price target for Guardant Health (NASDAQ:GH) from $130 to $135, maintaining an "over

### [Guardant Health | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 301.67 M](https://longbridge.com/en/news/285659279.md)
*2026-05-08T03:40:42.000Z*
### [Guardant Health (NASDAQ:GH) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS](https://longbridge.com/en/news/285645734.md)
*2026-05-08T01:20:13.000Z*
> Guardant Health (NASDAQ:GH) reported quarterly earnings of ($0.45) EPS, beating estimates of ($0.47) by $0.02. Revenue r